A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

NCT00262067 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1237

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Bevacizumab
DRUG: Placebo
DRUG: Chemotherapy

Sponsor

Genentech, Inc.